Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
Open Access
- 5 March 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 44 (8) , 1417-1432
Abstract
The brain is a highly demanding organ, utilizing mainly glucose but also ketone bodies as sources of energy. Glucose transporter-1 (GLUT1) and monocarboxylates transporter-1 (MCT1) respectively transport glucose and ketone bodies across the blood-brain barrier. While reduced glucose uptake by the brain is one of the earliest signs of Alzheimer’s disease (AD), no change in the uptake of ketone bodies has been evidenced yet. To probe for changes in GLUT1 and MCT1, we performed Western immunoblotting in microvessel extracts from the parietal cortex of 60 participants of the Religious Orders Study. Participants clinically diagnosed with AD had lower cerebrovascular levels of GLUT1, whereas MCT1 remained unchanged. GLUT1 reduction was associated with lower cognitive scores. No such association was found for MCT1. GLUT1 was inversely correlated with neuritic plaques and cerebrovascular β-secretase-derived fragment levels. No other significant associations were found between both transporters, markers of Aβ and tau pathologies, sex, age at death or apolipoprotein-ε4 genotype. These results suggest that, while a deficit of GLUT1 may underlie the reduced transport of glucose to the brain in AD, no such impairment occurs for MCT1. This study thus supports the exploration of ketone bodies as an alternative energy source for the aging brain.Keywords
This publication has 132 references indexed in Scilit:
- Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expressionAlzheimer's & Dementia, 2021
- Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive FunctionAnnals of Neurology, 2020
- Central Regulation of Glucose Homeostasis2017
- Near‐critical GLUT1 and NeurodegenerationJournal of Neuroscience Research, 2017
- Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's diseaseJournal of Neuroscience Research, 2016
- Brain imaging evidence of preclinical Alzheimer's disease in normal agingAnnals of Neurology, 2006
- Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive FunctionArchives of Neurology, 2004
- Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor ProteinNeurobiology of Disease, 2002
- Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's diseaseVirchows Archiv, 1994
- Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's diseaseAnnals of Neurology, 1994